Connect® MM- The Multiple Myeloma Disease Registry

Conditions:		Multiple Myeloma
Purpose:		The purpose of the Connect® MM Registry is to explore the natural history and real world management of patients with newly diagnosed symptomatic multiple myeloma (MM) and provide unique insights into the management of MM and the impact of this hematologic disorder on patients.
Study Summary:
Criteria:		Inclusion Criteria: - Newly diagnosed with symptomatic MM within 2 months of enrollment in Connect® MM registry - Age ≥18 years - Able to read and speak English - Willing and able to provide signed informed consent - Agrees to complete patient assessment questionnaires either alone or with minimal assistance from caregivers and/or trained site personnel Exclusion Criteria: • Participation in a clinical study in which study treatment is blinded
NCT ID:		NCT01081028
Primary Contact:		Study Director Mohamad Hussein, MD Celgene Corporation Kristen Sullivan Phone: 1-913-266-0329 Email: connectmm@celgene.com
Backup Contact:		N/A
Location Contact:		New Albany, Indiana 47150 United States *There is no listed contact information for this specific location.* Site Status: Recruiting

Data Source:		ClinicalTrials.gov
Date Processed:		June 18, 2013
Modifications to this listing:		Only selected fields are shown, please use the link below to view all information about this clinical trial.
Click to view Full Listing


If you would like to be contacted by the clinical trial representative please enter your contact information, then click "I Am Interested In This Study"

First Name:

Last Name:

Email Address:

Confirm Email:

Daytime Phone (eg. 555-555-5555):

City:

State:

Zip Code:

Best Time to Call:

Morning	Afternoon	Evening
Please contact me by email instead of calling.

Questions/Comments:

I have read and agree with the Privacy Policy

I have reviewed the eligibility criteria and believe I am eligible for this clinical trial

I would like to be notified about new clinical trials.